Supplement Support for PMS
This news is a cause for celebration among women across the globe: a special combination of essential fatty acids (EFA) has been found to prevent or significantly decrease the occurrence of premenstrual syndrome (PMS) symptoms. This means no more nasty cramps every month, thanks to essential fatty acids.
Proven True by Meticulous Research
A research study published in “Reproductive Health,” a BioMedCentral journal explains that experts from the Federal University of Pernambuco in Brazil tested the effect of EFA tablets in a controlled trial that included 120 women. According to the researchers, “the administration of 1 or 2 grams of essential fatty acids to patients with PMS resulted in a significant decrease in symptom scores. The administration of the EFA supplements did not result in any changes in the total cholesterol in the patients evaluated.” Research subjects were asked to consume EFA supplements that contained 2 grams of an EFA blend that included gamma linolenic acid, oleic acid, linoleic acid, some polyunsaturated acids, and vitamin E. After a minimum of three months, the subjects asserted that their PMS symptoms have been significantly reduced. Other subjects experienced positive results after six months. The women did report some adverse effects from the treatment, but such effects appeared to be unrelated or insignificant.
A Time to Rejoice
90% of women around the world suffer through PMS symptoms every month, from simple cramps to devastating depression. Thanks to this research study and thanks to EFA supplements, they no longer have to carry this burden, and they can improve their life in a significant way. As the researchers explained, “the negative effect of PMS on a woman’s routine activities and quality of life may be significant, in addition to the repercussions on economic costs resulting predominantly from a reduction in productivity. Essential fatty acids supplementation can now be said to show much promise as a treatment.”
Journal Reference: Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study. Reproductive Health, 2011.